| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5883067 | Clinical Lymphoma Myeloma and Leukemia | 2015 | 6 Pages |
Abstract
The t(v;5q33) is a rare cytogenetic aberration in AML. Although associated with a poor outcome, AML with t(v;5q33) usually lacks morphologic evidence of multilineage dysplasia. Patients who have AML with t(v;5q33) after MPN have a worse OS compared with those with de novo AML.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Mariko Yabe, Guilin Tang, Guillermo Garcia-Manero, Sanam Loghavi, Xinyan Lu, Roberto N. Miranda, L. Jeffrey Medeiros, Hagop M. Kantarjian, Carlos E. Bueso-Ramos, Joseph D. Khoury,